Publications by authors named "Mengye He"

Claim this Profile
I
Immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer patients with preexisting pulmonary emphysema or interstitial lung abnormalities.
Xi Chen, Caijuan Huan, Piao Yang, Mengye He, Ruiping Wang

Lung Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating ChatGPT's recommendations for systematic treatment decisions in recurrent or metastatic head and neck squamous cell carcinoma: Perspectives from experts and junior doctors.
Danfang Yan, Lihong Wang, Liming Huang, Kejia Cheng, Yu Huang, Mengye He

Int J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondria/lysosome dual-organelle labelling esterase probe for monitoring cell viability and evaluating lung cancer drug efficiency.
Mengye He, Jing Wang, Liping Wang, Bangping Hu, Xing-Can Shen, Hua Chen

Spectrochim Acta A Mol Biomol Spectrosc· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive nomogram integrating radiomics and multi-omics for improved prognosis-model in cholangiocarcinoma.
Yunlu Jia, Mingyu Wan, Yifei Shen, Junli Wang, Xiao Luo, Mengye He, Xiaochen Zhang

Clin Transl Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncogenic HJURP enhancer promotes the aggressive behavior of triple-negative breast cancer in association with p53/E2F1/FOXM1-axis.
Yunlu Jia, Yongxia Chen, Ming Chen, Mengye He, Suzhen Xu, Peng Shen, Xiaochen Zhang

Cancer Lett· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual-Labeled Single Fluorescent Probes for the Simultaneous Two-Color Visualization of Dual Organelles and for Monitoring Cell Autophagy.
Liping Wang, Mengye He, Xingyue Liu, Bang-Ping Jiang, Hua Chen, Xing-Can Shen

Anal Chem· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatty Acid Metabolism: A New Perspective in Breast Cancer Precision Therapy.
Mengye He, Suzhen Xu, Feifei Yan, Jian Ruan, Xiaochen Zhang

Front Biosci (Landmark Ed)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and molecular profiling of EGFR-mutant lung adenocarcinomas transformation to small cell lung cancer during TKI treatment.
Yongxia Chen, Mengye He, Zhengfeng Dai, Yina Wang, Jing Chen, Xiaochen Zhang, Peng Shen

Front Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Slippery Au Nanosphere Monolayers with Analyte Enrichment and SERS Enhancement Functions.
Xueyan Chen, Aoran Cui, Mengye He, Mi Yan, Xiaochen Zhang

Nano Lett· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long survival after immunotherapy plus paclitaxel in advanced intrahepatic cholangiocarcinoma: A case report and review of literature.
Meng-Ye He, Fei-Fei Yan, Kai-Li Cen, Peng Shen

World J Clin Cases· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha-fetoprotein-producing hepatoid adenocarcinoma of the lung responsive to sorafenib after multiline treatment: A case report.
Su-Zhen Xu, Xiao-Chen Zhang, Qi Jiang, Ming Chen, Meng-Ye He, Peng Shen

World J Clin Cases· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational engineering of biomimetic flavylium fluorophores for regulating the lysosomal and mitochondrial localization behavior by pH-induced structure switch and application to fluorescence imaging.
Liping Wang, Mengye He, Yu Sun, Li Liu, Yuan Ye, Xing-Can Shen, Hua Chen

J Mater Chem B· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sporoderm-Broken Spores of Sensitizes Ovarian Cancer to Cisplatin by ROS/ERK Signaling and Attenuates Chemotherapy-Related Toxicity.
Kaili Cen, Ming Chen, Mengye He, Zhenhao Li, Yinjing Song, Suzhen Xu, Peng Shen

Front Pharmacol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2 changes to positive after neoadjuvant chemotherapy in breast cancer: A case report and literature review.
Luo Wang, Qi Jiang, Meng-Ye He, Peng Shen

World J Clin Cases· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARP inhibitor treatment of advanced breast cancer beyond the -mutated type: a meta-analysis.
Feifei Yan, Qi Jiang, Mengye He, Peng Shen

Future Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PITX2 methylation: a novel and effective biomarker for monitoring biochemical recurrence risk of prostate cancer.
Qi Jiang, Mixue Xie, Mengye He, Feifei Yan, Ming Chen, Suzhen Xu, Xiaochen Zhang, Peng Shen

Medicine (Baltimore)· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinctive features of immunostaining and mutational load in primary pulmonary enteric adenocarcinoma: implications for differential diagnosis and immunotherapy.
Ming Chen, Pu Liu, Feifei Yan, Suzhen Xu, Qi Jiang, Mengye He, Peng Shen

J Transl Med· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-PD-1/PD-L1 antibodies versus docetaxel in patients with previously treated non-small-cell lung cancer.
Qi Jiang, Mixue Xie, Mengye He, Feifei Yan, Xiaochen Zhang

Oncotarget· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Advances on correlation of PET-CT findings with breast cancer molecular subtypes, treatment response and prognosis].
Jingying Pan, Mengye He, Wei Ke, Menglin Hu, Meifang Wang, Peng Shen

Zhejiang Da Xue Xue Bao Yi Xue Ban· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of ERα/ERK/P62 cascades induces "autophagic switch" in the estrogen receptor-positive breast cancer cells exposed to gemcitabine.
Peng Shen, Ming Chen, Mengye He, Luoquan Chen, Yinjing Song

Oncotarget· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cytoprotective role of gemcitabine-induced autophagy associated with apoptosis inhibition in triple-negative MDA-MB-231 breast cancer cells.
Ming Chen, Mengye He, Yinjing Song, Luoquan Chen, Peng Xiao, Peng Shen

Int J Mol Med· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased circulating Lin(-/low) CD33(+) HLA-DR(-) myeloid-derived suppressor cells in hepatocellular carcinoma patients.
Peng Shen, Aijuan Wang, Mengye He, Qingqing Wang, Shusen Zheng

Hepatol Res· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis